201. Endovascular therapy of bronchial artery aneurysm: five cases with six aneurysms.
- Author
-
Lü PH, Wang LF, Su YS, Lee DH, Wang SX, Sun L, Geng SP, Huang WN, Lü, Peng-Hua, Wang, Li-Fu, Su, Yu-Sheng, Lee, Deok-Hee, Wang, Shu-Xiang, Sun, Ling, Geng, Su-Ping, and Huang, Wen-Nuo
- Abstract
The objective of this study was to investigate the effect of transcatheter arterial embolization (TAE) with N-butyl-2-cyanoacrylate (NBCA)-Lipiodol mixture in patients with bronchial artery aneurysm (BAA). From January 2005 to January 2010, five patients presenting hemoptysis with six BAAs were treated with NBCA-Lipiodol mixture, including intra-aneurysm embolization (IAE) in one patient. Adjuvant embolization with spherical polyvinyl alcohol (PVA) embolic microparticles or NBCA was first performed to embolize the distal engorged bronchiectatic arteries. Bronchial arterial angiography showed six BAAs (four in the right lobe and two in the left lobe) and some engorged, tortuous bronchial arteries. TAE through microcatheter was successful in all cases. Postembolization angiogram demonstrated the NBCA cast and total occlusion of BAAs and bronchiectatic engorged vessels. After these procedures, hemoptysis completely disappeared in all patients. Follow-up computed tomography (CT) scan was performed at an average of 3 months (range 2 to 6), which showed no enhancement of BAAs and accumulation of NBCA. TAE is a minimally invasive, effective, and reliable approach for treatment for patients with BAA. NBCA-Lipiodol mixture provides a good choice for treatment of BAA, especially when catheterization of the efferent branches is impossible. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF